etoposide has been researched along with enkephalin, leucine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Charcosset, JY; Garbay-Jaureguiberry, C; Jacquemin-Sablon, A; Rigaudy, P; Roques, BP | 1 |
| Copeland, LA; McTavish, N; Perkins, ND; Saville, MK; Spruce, BA | 1 |
2 other study(ies) available for etoposide and enkephalin, leucine
| Article | Year |
|---|---|
Attempts to target antitumor drugs toward opioid receptor-rich mouse tumor cells with enkephalin-ellipticinium conjugates.
Topics: Alkaloids; Animals; DNA; DNA Topoisomerases, Type II; Drug Carriers; Ellipticines; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Etoposide; Fluorescence; Mice; Rats; Receptors, Opioid | 1989 |
Proenkephalin assists stress-activated apoptosis through transcriptional repression of NF-kappaB- and p53-regulated gene targets.
Topics: Animals; Apoptosis; Cell Line; Cell Line, Tumor; Cell Nucleus; Cell Survival; Enkephalins; Etoposide; Humans; NF-kappa B; Protein Precursors; Repressor Proteins; RNA Interference; Transcription Factor RelA; Transcription, Genetic; Tumor Suppressor Protein p53 | 2007 |